Supernus Pharmaceuticals shares owned by Aristotle Capital Boston
Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Aristotle Capital Boston
from 13F filings
Historical chart of Aristotle Capital Boston investment in Supernus Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Supernus Pharmaceuticals held by Aristotle Capital Boston consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Supernus Pharmaceuticals by Aristotle Capital Boston
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $15M | 305k | 47.79 |
| 2025-06-30 | $26M | 808k | 31.52 |
| 2025-03-31 | $29M | 873k | 32.75 |
| 2024-12-31 | $39M | 1.1M | 36.16 |
| 2024-09-30 | $37M | 1.2M | 31.18 |
| 2024-06-30 | $32M | 1.2M | 26.75 |
| 2024-03-31 | $39M | 1.1M | 34.11 |
| 2023-09-30 | $33M | 1.2M | 27.57 |
| 2023-06-30 | $35M | 1.2M | 30.06 |
| 2023-03-31 | $42M | 1.2M | 36.23 |
| 2022-12-31 | $40M | 1.1M | 35.67 |
| 2022-09-30 | $39M | 1.2M | 33.85 |
| 2022-06-30 | $37M | 1.3M | 28.92 |
| 2022-03-31 | $41M | 1.3M | 32.32 |
| 2021-12-31 | $38M | 1.3M | 29.16 |
| 2021-09-30 | $35M | 1.3M | 26.67 |
| 2021-06-30 | $33M | 1.1M | 30.79 |
| 2021-03-31 | $26M | 973k | 26.18 |
| 2020-12-31 | $26M | 1.0M | 25.16 |
| 2020-09-30 | $22M | 1.1M | 20.84 |
| 2020-06-30 | $24M | 1.0M | 23.75 |
| 2020-03-31 | $13M | 741k | 17.99 |
| 2019-12-31 | $18M | 758k | 23.72 |
| 2019-09-30 | $20M | 744k | 27.48 |
| 2019-06-30 | $3.4M | 104k | 33.09 |